首頁 › 軟組織肉瘤 › 紐約州 › New York City
New York City, NY 的 軟組織肉瘤 臨床試驗
19 項針對 軟組織肉瘤 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of CRD3874-SI in People With Solid Tumors
招募中1 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
招募中1/2 期
- Memorial Sloan Kettering Cancer Center, New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
招募中1/2 期
- New York University Langone Health, New York
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
招募中1/2 期
- Memorial Sloan Kettering Cancer Center, New York
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
招募中1 期
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
招募中1 期
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
招募中
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Actinium Therapy for Late-stage Aggressive Sarcomas
招募中1 期
- Memorial Sloane Kettering Cancer Center, New York
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
招募中觀察性研究
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
招募中2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
招募中1 期
- Zai Lab Site 02002, New York
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
招募中
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
招募中2 期
- Memorial Sloan Kettering Cancer Centre, New York
Phase II Trial of Lung Chemoemobolization
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
招募中1/2 期
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
招募中1/2 期
- Memorial Sloan-Kettering Cancer Center, New York
其他城市的 軟組織肉瘤 試驗
- Houston, TX32 項研究
- Boston, MA18 項研究
- St. Louis, MO14 項研究
- Los Angeles, CA13 項研究
- Columbus, OH13 項研究
- Washington, DC12 項研究
- Memphis, TN11 項研究
- Philadelphia, PA10 項研究
- Nashville, TN9 項研究
- Rochester, MN9 項研究
- Queens, NY9 項研究
- Aurora, CO9 項研究
New York City 的其他研究
- 乳癌136 項研究
- 非小細胞肺癌121 項研究
- 癌症（所有類型）109 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌78 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 多發性骨髓瘤60 項研究
- 胰臟癌60 項研究
- 子宮內膜癌52 項研究
- 急性髓系白血病51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。